Trainee (Relationship between study population,subgroup analyses & indication for cancer medicines)

Job title:

Trainee (Relationship between study population,subgroup analyses & indication for cancer medicines)

Company:

European Medicines Agency

Job description

Selection procedure reference: EMA/TR/10911Deadline for applications: 6 May 2025 23:59 CETThe European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.This traineeship opportunity is now open for applications until 6 May 2025 23:59 CET, with an intake on 1 October 2025.About the traineeship programmeThe Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master’s students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.Placement descriptionWe are looking for a trainee in the Therapeutic Areas Department.Specific objectives and projectsRecent developments in cancer diagnosis and treatment have dramatically improved survival rates and quality of life for cancer patients, with cancer medicines representing the therapeutic area with the most number of approvals.Since further development and spending on cancer drugs are expected to continue to rise, and as the joint clinical assessments are kicking off with cancer medicines, it is important to take stock of the experience to understand the relationship between the clinical data (focusing on study population and subgroup analyses) and the finally agreed indication to further inform future assessments and potentially better alignment between regulatory and reimbursement decisions.The trainee will be expected, with support from relevant colleagues, to identify products in scope and retrieve, from their assessment reports, the discussion and rationale for the agreed indication, as well as the details of the clinical data provided specifically with regard to the studied patient population and subgroup analyses; the trainee will then be expected to evaluate the impact of such elements and draw learnings as part of a report or a potential publication.Learning outcomesThrough this work, the trainee will:
– gain insight in the review and approval of cancer medicines,
– familiarise themselves with the centralised procedure review process and EU regulatory framework,
– enhance existing skills in data analysis, scientific writing and communication.Eligibility criteriaTo be eligible for consideration for this placement, you are required to: * enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;

• possess a university degree in pharmacy, medicine or life sciences (minimum of three years or more) that must have been obtained between 6 May 2024 and 6 May 2025 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master’s student with a previous fully finished degree in the areas mentioned before.
• a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.Additional skills

• Good analytical and communication skills.
• It is an advantage if you already have existing knowledge in cancer and/or medical statistics.

Behavioural CompetenciesYou will demonstrate the following behavioural competencies:

• Communication skills
• Interpersonal skills
• Working with others
• Adaptability
• Research and analytical skills
• Learning and development

Expected selection timelinesDeadline for applications 6 May 2025 23:59 CET
Assessments (remote) From end of June 2025 to mid-July 2025
Decision and offers By end of July 2025
Placement start 1 October 2025Conditions of traineeshipThe traineeship is offered for 10 months (1 October 2025 – 31 July 2026) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.The Agency pays a monthly stipend of €1,942.19 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.Each trainee will have a mentor at the Agency who will guide the trainee through the programme.The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available .Domenico Scarlattilaan 6 – 1083 HS Amsterdam – The NetherlandsTelephone +31 (0)88 781 6000 – Email© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.Join us to work for every patient in Europe!Who we are?Serving a population of 500 million citizens, we promote and protect public animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.What do we offer?

• Meaningful work contributing to protecting the health of every individual and animal in Europe within multinational, multidisciplinary team
• Development opportunities (e.g. internal mobility, mentoring, peer coaching, career reflection programme, etc.)
• Work-life balance (flexible working arrangements, teleworking, generous annual leave plus official holidays)

Benefits(applicable only to Temporary and Contract vacancies)

• Initial 5 year contract with competitive monthly tax-free salary and household & children’s allowances (where applicable)
• Privileges for expatriate staff including expatriation and education allowances (where appropriate) and additional home leave
• Relocation assistance
• Excellent health insurance scheme and social benefits
• Retirement Pension Plan

Read more aboutUseful links:

Expected salary

€1942.19 per month

Location

Amsterdam, Noord-Holland

Job date

Wed, 19 Mar 2025 08:42:38 GMT

To help us track our recruitment effort, please indicate in your email/cover letter where (vacanciesin.eu) you saw this job posting.